Latest Indian Govt. decisions will change the face of the Pharma Sector

New Delhi : Here comes a time to see how Govt. decisions shape Indian Pharma industry. Indian Govt. implemented GST for Pharma manufacturers to control the prices of medicines and on next step to start e-portals for the sale of medicines. Central government’s policy is all ready to launch a centralized online pharmacy that will involve pharma manufacturers and supply chain managers to develop a safe system to control the sale of drugs.

India Pharma Industry worried about the consequences and foresees long term impact of latest govt. policies. Indian Chemists and Druggists will most affect by this online system as this will reduce their sales, profit margins etc.

All India Organisation of Chemists and Druggists (AIOCD) protested nationwide against plan of e-portal. But government not seems to make change in their decision.

These policies favors consumers but the main concern is about the quality and delivery service of that portal. Some people appreciate this as a part of Prime Minister’s Digital India movement. The medicines will be supplied only if consumer has a valid prescription. This will give control to the government to understand pharma business from its ins and outs.

Information Technology (IT) Act, 2000 and Drugs and Cosmetics Act, 1940 governed online pharmacy but decision made on the broad contours of a policy on any of the stakeholders’ recommendations.

Last meeting of Drug Consultative Committee held on 6th November, 2016 under the chairmanship of Dr Harshadeep Kamble, Maharashtra Food and Drug Administration (FDA) Commissioner. Committee has accepted the recommendations of a select group of state drug regulators on online pharmacy.

Government simply wants to make use of new technology to smoothen the process of pharma industry to help consumers. But the main concerns of the Chemists and Druggists are cut in profit margins and strong market competition from the e-portals.

  • Related Posts

    MedTech Zone AMTZ Puts Vizag on the Science Map of India

    Vizag Science &Technology Cluster rated as one of the India’s Strategic Innovation Hubs Visakhapatnam, June 28 – In a significant boost to Vizag’s growing scientific stature, the Andhra Pradesh MedTech…

    • News
    • May 27, 2025
    • 267 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July